This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ propoxycaine hydrochloride,(prescription)

AI Engines For more Details: Perplexity  Kagi Labs  You 

  1. Local Anesthesia: Propoxycaine hydrochloride works by blocking nerve signals in a specific area of the body, resulting in temporary loss of sensation. It is commonly used for procedures such as dental work, minor surgeries, and dermatological procedures.

  2. Short-Acting: Propoxycaine hydrochloride is a short-acting local anesthetic, meaning its effects wear off relatively quickly compared to other local anesthetics. This property makes it suitable for brief procedures or when rapid onset and recovery of anesthesia are desired.

  3. Low Systemic Toxicity: When used as directed, propoxycaine hydrochloride typically has low systemic toxicity, meaning it has minimal effects on other parts of the body beyond the area where it is applied. However, like all local anesthetics, it can potentially cause adverse reactions if absorbed into the bloodstream in excessive amounts.

  4. Side Effects: Common side effects associated with the use of propoxycaine hydrochloride may include temporary numbness, tingling, or burning sensation at the site of administration. Rarely, allergic reactions such as rash, itching, or swelling may occur.

  5. Systemic Toxicity: While rare, systemic toxicity can occur if propoxycaine hydrochloride is inadvertently injected into a blood vessel or absorbed in large amounts. Symptoms of systemic toxicity may include dizziness, confusion, seizures, respiratory depression, and cardiovascular collapse. Prompt recognition and treatment of systemic toxicity are essential to prevent serious complications.

  6. Drug Interactions: Propoxycaine hydrochloride may interact with certain medications, such as other local anesthetics or medications that affect the cardiovascular system, increasing the risk of adverse effects. Healthcare providers should be aware of potential drug interactions and adjust dosages accordingly.

  7. Pregnancy and Breastfeeding: The safety of propoxycaine hydrochloride use during pregnancy and breastfeeding has not been well established. Healthcare providers should weigh the potential risks and benefits before administering propoxycaine hydrochloride to pregnant or breastfeeding individuals.

;

Check for interactions on Supp.AI   |   📚 PubMed Citations

⚗️ Compensation for antibiotic usage

Data Contradictions — Limits of Certainity

Impacted of propoxycaine hydrochloride,(prescription) On Probiotics

Rank Probiotic Impact
species Anaerobutyricum hallii Reduces
species Christensenella minuta Reduces
species Enterococcus faecium Reduces
species Lacticaseibacillus paracasei Reduces
species Lactococcus cremoris Reduces

Bacteria Impacted by propoxycaine hydrochloride,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

🧙?

📓 Direct Citations 👪👶 Indirect Citations Taxonomy Rank Effect
0 1 Coprococcus genus Decreases
0 1 Lacticaseibacillus genus Decreases
0 1 Parabacteroides genus Decreases
0 1 Roseburia genus Decreases
0 1 Ruminococcus genus Decreases
0 1 Eggerthella genus Decreases
1 0 Coprococcus comes species Decreases
1 0 Lacticaseibacillus paracasei species Decreases
1 0 Parabacteroides merdae species Decreases
0 1 Coprococcus catus species Decreases
0 1 Dorea longicatena species Decreases
0 1 Lactococcus cremoris species Decreases
0 1 Blautia obeum species Decreases
0 1 Streptococcus suis species Decreases
0 1 Dorea formicigenerans species Decreases
0 1 Wansuia hejianensis species Decreases
0 1 Mageeibacillus indolicus species Decreases
0 1 Adlercreutzia equolifaciens species Decreases
0 1 Anaerobutyricum hallii species Decreases
0 1 Chordicoccus furentiruminis species Decreases
0 1 Ligilactobacillus ruminis species Decreases
0 1 Blautia sp. SC05B48 species Decreases
0 1 Adlercreutzia hattorii species Decreases
0 1 Lacrimispora saccharolytica species Decreases
0 1 Subdoligranulum variabile species Decreases
0 1 Fannyhessea vaginae species Decreases
0 1 Butyrivibrio crossotus species Decreases
0 1 [Ruminococcus] lactaris species Decreases
0 1 Komagataeibacter oboediens species Decreases
0 1 Clostridium sp. M62/1 species Decreases
0 1 Eubacterium ventriosum species Decreases
0 1 Bacillus paralicheniformis species Decreases
0 1 Acutalibacter muris species Decreases
0 1 Coprococcus eutactus species Decreases
0 1 Eubacterium sp. c-25 species Decreases
0 1 Clostridium sp. SY8519 species Decreases
0 1 Parvimonas micra species Decreases
0 1 [Ruminococcus] torques species Decreases
0 1 Faecalibaculum rodentium species Decreases
0 1 Lachnoanaerobaculum gingivalis species Decreases
0 1 Enterococcus faecium species Decreases
0 1 Blautia liquoris species Decreases
0 1 Mogibacterium diversum species Decreases
0 1 Coprococcus sp. ART55/1 species Decreases
1 0 Roseburia intestinalis species Decreases
0 1 Christensenella minuta species Decreases
0 1 Faecalibacterium duncaniae species Decreases
0 1 Treponema denticola species Decreases
0 1 Massilistercora timonensis species Decreases
0 1 Actinomyces oris species Decreases
0 1 Eubacterium sp. MSJ-33 species Decreases
0 1 Catenibacterium mitsuokai species Decreases
0 1 Vescimonas fastidiosa species Decreases
0 1 Faecalitalea cylindroides species Decreases
0 1 Roseburia hominis species Decreases
0 1 Roseburia rectibacter species Decreases
0 1 Treponema peruense species Decreases
0 1 Qiania dongpingensis species Decreases
0 1 Novisyntrophococcus fermenticellae species Decreases
0 1 Maliibacterium massiliense species Decreases
0 1 Catenibacterium sp. co_0103 species Decreases
0 1 Pseudobutyrivibrio xylanivorans species Decreases
0 1 Emergencia timonensis species Decreases
0 1 Eubacterium limosum species Decreases
0 1 Faecalibacterium sp. I2-3-92 species Decreases
0 1 Faecalibacterium sp. HTF-F species Decreases
0 1 [Clostridium] hylemonae species Decreases
0 1 Faecalibacterium sp. I4-1-79 species Decreases
0 1 Ruminococcus albus species Decreases
0 1 Phascolarctobacterium sp. Marseille-Q4147 species Decreases
0 1 Corynebacterium durum species Decreases
0 1 Eubacterium maltosivorans species Decreases
0 1 [Eubacterium] hominis species Decreases
0 1 Phascolarctobacterium succinatutens species Decreases
0 1 Faecalibacillus intestinalis species Decreases
0 1 Butyrivibrio fibrisolvens species Decreases
0 1 Intestinibaculum porci species Decreases
0 1 Faecalibacterium sp. IP-3-29 species Decreases
0 1 Eubacterium callanderi species Decreases
0 1 Olsenella sp. oral taxon 807 species Decreases
0 1 Ruminococcus champanellensis species Decreases
0 1 Butyricicoccus sp. GAM44 species Decreases
0 1 Wujia chipingensis species Decreases
0 1 Anaerostipes hadrus species Decreases
0 1 Clostridium cadaveris species Decreases
0 1 Ruthenibacterium lactatiformans species Decreases
0 1 Faecalibacterium sp. I3-3-89 species Decreases
0 1 Phoenicibacter congonensis species Decreases
0 1 Longicatena caecimuris species Decreases
0 1 Marvinbryantia formatexigens species Decreases
0 1 Actinomyces naeslundii species Decreases
0 1 Vescimonas coprocola species Decreases
0 1 Lachnoclostridium phocaeense species Decreases
0 1 Ruminococcus bicirculans (ex Wegman et al. 2014) species Decreases
0 1 Faecalibacterium sp. IP-1-18 species Decreases
0 1 Lawsonibacter asaccharolyticus species Decreases
0 1 Faecalibacterium sp. I4-3-84 species Decreases
0 1 Alistipes ihumii species Decreases
0 1 Streptococcus sanguinis species Decreases
0 1 Clostridium sp. C1 species Decreases
0 1 Alistipes indistinctus species Decreases
0 1 Solibaculum mannosilyticum species Decreases
0 1 Monoglobus pectinilyticus species Decreases
0 1 Ruminococcus gauvreauii species Decreases
0 1 Oscillibacter hominis species Decreases
0 1 Rothia dentocariosa species Decreases
0 1 [Clostridium] scindens species Decreases
0 1 uncultured Alistipes sp. species Decreases
1 0 Ruminococcus bromii species Decreases
1 0 Eggerthella lenta species Decreases
0 1 Lacticaseibacillus paracasei subsp. paracasei subspecies Decreases
0 1 Lacticaseibacillus paracasei subsp. tolerans subspecies Decreases

Impact of propoxycaine hydrochloride,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
ADHD 0.3 0.7 -1.33
Age-Related Macular Degeneration and Glaucoma 0.2 0.2 0
Allergic Rhinitis (Hay Fever) 0.3 0.2 0.5
Allergies 0.8 0.1 7
Allergy to milk products 0.4 0.4 0
Alopecia (Hair Loss) 0.1 -0.1
Alzheimer's disease 0.7 1.1 -0.57
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.3 0.2 0.5
Ankylosing spondylitis 0 0
Anorexia Nervosa 0.2 0.1 1
Antiphospholipid syndrome (APS) 0.2 0.2
Asthma 0.1 0.1 0
Atherosclerosis 0.3 0.2 0.5
Atrial fibrillation 0.5 0.2 1.5
Autism 1 0.8 0.25
Autoimmune Disease 0.1 -0.1
Biofilm 0.1 0.1
Bipolar Disorder 0.2 0.5 -1.5
Brain Trauma 0.1 0.1 0
Cancer (General) 0.7 -0.7
Carcinoma 0.2 0.2 0
Celiac Disease 0.2 0.2 0
Cerebral Palsy 0.1 -0.1
Chronic Fatigue Syndrome 0.8 2.4 -2
Chronic Kidney Disease 0.6 0.9 -0.5
Chronic Lyme 0.1 -0.1
Chronic Obstructive Pulmonary Disease (COPD) 0.3 0.4 -0.33
Coagulation / Micro clot triggering bacteria 0.2 0.1 1
Cognitive Function 0.2 0.1 1
Colorectal Cancer 0.4 0.2 1
Constipation 0 0.1 0
Coronary artery disease 0.2 0.7 -2.5
COVID-19 1.4 2.6 -0.86
Crohn's Disease 0.8 0.8 0
cystic fibrosis 0.1 -0.1
deep vein thrombosis 0.3 0.1 2
Denture Wearers Oral Shifts 0.1 0.1
Depression 1.7 2.7 -0.59
Endometriosis 0.5 0.4 0.25
Epilepsy 0.2 0.5 -1.5
Fibromyalgia 0.8 0.7 0.14
Functional constipation / chronic idiopathic constipation 0.7 0.8 -0.14
gallstone disease (gsd) 0.4 0.1 3
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.5 -0.5
Generalized anxiety disorder 0.3 0.3 0
Gout 0 0.3 0
Graves' disease 0.2 0.2 0
Gulf War Syndrome 0.3 0.3
Halitosis 0.1 -0.1
Hashimoto's thyroiditis 0.5 0.2 1.5
Heart Failure 0.6 0.3 1
hemorrhagic stroke 0.2 0.2
High Histamine/low DAO 0.1 0 0
hypercholesterolemia (High Cholesterol) 0.2 -0.2
hyperglycemia 0.2 -0.2
hypertension (High Blood Pressure 0.7 0.6 0.17
Hypothyroidism 0.3 -0.3
Hypoxia 0.2 0.2
IgA nephropathy (IgAN) 0.2 0.2 0
Inflammatory Bowel Disease 0.6 1.5 -1.5
Insomnia 0.5 0.1 4
Intelligence 0.3 0.3
Intracranial aneurysms 0.2 0.3 -0.5
Irritable Bowel Syndrome 0.3 0.6 -1
ischemic stroke 0.2 0.1 1
Liver Cirrhosis 0.8 0.4 1
Long COVID 1.3 1.2 0.08
Low bone mineral density 0.7 -0.7
Lung Cancer 0.2 -0.2
Mast Cell Issues / mastitis 0.4 -0.4
ME/CFS with IBS 1.7 -1.7
ME/CFS without IBS 0.4 0.4 0
Menopause 0.2 0.2 0
Metabolic Syndrome 0.8 1.1 -0.38
Mood Disorders 1.8 2.2 -0.22
Multiple Sclerosis 0.5 0.9 -0.8
Multiple system atrophy (MSA) 0.1 0 0
myasthenia gravis 0.1 -0.1
neuropathic pain 0 0.4 0
Neuropathy (all types) 0 0.2 0
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 0.5 0.8 -0.6
NonCeliac Gluten Sensitivity 0 0
Obesity 1.5 1.8 -0.2
obsessive-compulsive disorder 0.8 0.5 0.6
Osteoarthritis 0.3 0.2 0.5
Osteoporosis 0.1 0.1
Parkinson's Disease 1.7 1.2 0.42
Polycystic ovary syndrome 1.2 0.2 5
Postural orthostatic tachycardia syndrome 0.3 -0.3
Premenstrual dysphoric disorder 0.2 -0.2
Primary sclerosing cholangitis 0.3 1.1 -2.67
Psoriasis 0.2 0.6 -2
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 1.2 0.4 2
Rosacea 0.2 0.1 1
Schizophrenia 0.9 0.6 0.5
scoliosis 0.5 0 0
sensorineural hearing loss 0.4 0.4
Sjögren syndrome 0.2 0.2 0
Sleep Apnea 0.4 0.4 0
Slow gastric motility / Gastroparesis 0 0
Small Intestinal Bacterial Overgrowth (SIBO) 0.5 0.5
Stress / posttraumatic stress disorder 0.2 0.6 -2
Systemic Lupus Erythematosus 0.5 0.3 0.67
Tic Disorder 0 0.3 0
Type 1 Diabetes 0.5 0.3 0.67
Type 2 Diabetes 1 0.9 0.11
Ulcerative colitis 0.7 1.1 -0.57
Unhealthy Ageing 0.5 0.6 -0.2
Vitiligo 0.2 0.8 -3

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]